EP3221320 - A PROCESS FOR THE PREPARATION OF IBRUTINIB [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.10.2020 Database last updated on 20.05.2024 | |
Former | Examination is in progress Status updated on 05.02.2020 | ||
Former | Request for examination was made Status updated on 25.08.2017 | ||
Former | The international publication has been made Status updated on 15.06.2017 | Most recent event Tooltip | 16.10.2020 | Application deemed to be withdrawn | published on 18.11.2020 [2020/47] | Applicant(s) | For all designated states Sun Pharmaceutical Industries Ltd Sun House, Plot N°. 201 B/1 Western Express Highway Goregoan (E) 400063 Mumbai, Maharashtra / IN | [2017/39] | Inventor(s) | 01 /
SHARMA, Kapil House Number 1692/7 Gali Mule Wali Chonk Moni Amritsar Punjab 143001 / IN | 02 /
THANKI, Bhavin Prabhudas 32 Ankur Nagar Timbawadi Junagadh Gujarat 362015 / IN | 03 /
KHANNA, Mahavir Singh C-36A Jitar Nagar Parwana Road New Delhi Delhi 110051 / IN | 04 /
PRASAD, Mohan D-50, Green Woods City, Sector - 46 122003 Gurgaon, Haryana / IN | [2017/43] |
Former [2017/39] | 01 /
SHARMA, Kapil House Number 1692/7 Gali Mule Wali Chonk Moni Amritsar Punjab 143001 / IN | ||
02 /
THANKI, Bhavin Prabhudas 32 Ankur Nagar Timbawadi Junagadh Gujarat 362015 / IN | |||
03 /
KHANNA, Mahavir Singh C-36A Jitar Nagar Parwana Road New Delhi Delhi 110051 / IN | |||
04 /
PRASAD, Mohan H.No.P-3/3 Phase-II DLF Qutab Enclave Gurgaon Haryana 122001 / IN | Representative(s) | Cronin, Brian Harold John c/o Gsmart IP SA Route de Florissant 81 1206 Genève / CH | [N/P] |
Former [2017/39] | Cronin, Brian Harold John CRONIN Intellectual Property Chemin de Précossy 31 1260 Nyon / CH | Application number, filing date | 15860646.7 | 18.11.2015 | [2017/39] | WO2015IB58933 | Priority number, date | IN2014DEL3343 | 19.11.2014 Original published format: IN 3343DE2014 | [2017/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016079693 | Date: | 26.05.2016 | Language: | EN | [2016/21] | Type: | A1 Application with search report | No.: | EP3221320 | Date: | 27.09.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.05.2016 takes the place of the publication of the European patent application. | [2017/39] | Search report(s) | International search report - published on: | US | 26.05.2016 | (Supplementary) European search report - dispatched on: | EP | 23.03.2018 | Classification | IPC: | C07D487/04 | [2017/39] | CPC: |
C07D487/04 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/39] | Title | German: | VERFAHREN ZUR HERSTELLUNG VON IBRUTINIB | [2017/39] | English: | A PROCESS FOR THE PREPARATION OF IBRUTINIB | [2017/39] | French: | PROCÉDÉ DE PRÉPARATION D'IBRUTINIB | [2017/39] | Entry into regional phase | 19.06.2017 | National basic fee paid | 19.06.2017 | Search fee paid | 19.06.2017 | Designation fee(s) paid | 19.06.2017 | Examination fee paid | Examination procedure | 12.06.2017 | Date on which the examining division has become responsible | 19.06.2017 | Examination requested [2017/39] | 09.10.2018 | Amendment by applicant (claims and/or description) | 10.02.2020 | Despatch of a communication from the examining division (Time limit: M04) | 23.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/47] | 14.07.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/47] | Fees paid | Renewal fee | 30.11.2017 | Renewal fee patent year 03 | 30.11.2018 | Renewal fee patent year 04 | 02.12.2019 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]US2002156081 (HIRST GAVIN C [US], et al) [X] 13-16 * [0352], in particular Scheme I, Scheme II and Scheme X; [3639]-[3640] * [Y] 1-12,17-20; | [Y]US8158786 (HONIGBERG LEE [US], et al) [Y] 1-12,17-20 * columns 56-57, Scheme 1; see column 57, lines 37-56; examples, e.g. Example 1, Examples 1a-1c and Scheme 1; claims *; | [Y]WO2013191965 (PRINCIPIA BIOPHARMA INC [US]) [Y] 1-12,17-20* Example 12, and in particular step 7 * | International search | [X]US2002156081 (HIRST GAVIN C [US], et al) [X] 4, 13 * entire document *; | [A]WO02076986 (ABBOTT GMBH & CO KG [DE], et al) [A] 1-23, 37-40 * entire document *; | [A]US2014221333 (DE MAN ADRIANUS PETRUS ANTONIUS [NL], et al) [A] 1-23, 37-40 * entire document *; | [A]US8673925 (GOLDSTEIN DAVID MICHAEL [US]) [A] 1-23, 37-40 * entire document * |